| Teva Pharma AG - Ipramol Steri-Nebs, Lösung für einen Vernebler |
| 58253 | | 01 | | Ipramol Steri-Nebs | | Lösung für einen Vernebler | | R03AL02 | | Salbutamol and Ipratropium Bromide | | 03.06.2008 | | |
|
| Composition |
| ipratropii bromidum 0.52 mg corresp. ipratropii bromidum anhydricum 0.5 mg, salbutamoli sulfas 3 mg corresp. salbutamolum 2.5 mg, natrii chloridum, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile ad solutionem pro 2.5 ml. |
| Packungsbestandteile |
| Inhalation solution | | | | | | | | Active Agent | Dose |
|---|
| Ipratropii Bromide | 0.52 mg correspond Ipratropii Bromide Anhydrate 0.5 mg | | Salbutamol Sulfate | 3 mg correspond Salbutamol 2.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Ipratropii Bromide Anhydrate | 0.5 mg | | Salbutamol | 2.5 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Sodium Chloride |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 60 unidose(s) | 13.60 | 31.20 | B | SL | No |
|
